Replacing one serving of sugary drink every day may lower diabetes risk
the ONA take:
According to research published in the journal Diabetologia, researchers have found that replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes by 14 to 25%.
Specifically, researchers found that replacing a serving of a soft drink with water, unsweetened tea, or coffee cuts the risk of diabetes by 14%. Replacing a serving of a sweetened milk beverage with either of the three reduces the risk by 20-25%.
The study also showed that for each 5% of higher intake of energy from total sweet beverages was linked with an 18% increased risk for diabetes.
The researchers determined that if participants had decreased the energy they obtained from sweet beverages to below 2% of total daily energy, 15% of new diabetes cases could be avoided.
"Our new findings on the potential to reduce the burden of diabetes by reducing the percentage of energy consumed from sweet beverages add further important evidence to the recommendation from the World Health Organization to limit the intake of free sugars in our diet," lead researcher Dr. Nita Forouhi, of the UK Medical Research Council Epidemiology Unit, University of Cambridge, said.
Replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|